Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Herbst

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Molecular Cancer Therapeutics|October 17, 2006
Induction of apoptosis by monastrol, an inhibitor of the mitotic kinesin Eg5, is independent of the spindle checkpointGregory M Chin, Ronald Herbst
Cancer Research|January 11, 2007
Potentiation of kinesin spindle protein inhibitor-induced cell death by modulation of mitochondrial and death receptor apoptotic pathwaysUlka Vijapurkar, Wei Wang, Ronald Herbst
The Journal of Biological Chemistry|September 18, 2002
The tyrosine phosphatase PRL-1 localizes to the endoplasmic reticulum and the mitotic spindle and is required for normal mitosisJing Wang, Celeste E Kirby, Ronald Herbst
International Journal of Rheumatic Diseases|October 23, 2012
Biomarkers for systemic lupus erythematosusRonald Herbst, Zheng Liu, Bahija Jallal, et al.
Cancer Metastasis Reviews|January 22, 2009
Kinesin motor proteins as targets for cancer therapyDennis Huszar, Maria-Elena Theoclitou, Jeffrey Skolnik, et al.
Arthritis Research & Therapy|April 10, 2013
B-cell targeted therapeutics in clinical developmentStephan Blüml, Kathleen McKeever, Rachel Ettinger, et al.
Molecular Immunology|June 9, 2014
Discerning the kinetics of autoimmune manifestations in a model of Sjögren's syndromeJodi L Karnell, Tamer I Mahmoud, Ronald Herbst, et al.
European Journal of Immunology|March 11, 2015
ICOS is required for the generation of both central and effector CD4(+) memory T-cell populations following acute bacterial infectionClare L Marriott, Gianluca Carlesso, Ronald Herbst, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2017
IL-22 Increases Permeability of Intestinal Epithelial Tight Junctions by Enhancing Claudin-2 ExpressionYaya Wang, John Brian Mumm, Ronald Herbst, et al.
Journal of Clinical Medicine|November 26, 2016
Inebilizumab, a B Cell-Depleting Anti-CD19 Antibody for the Treatment of Autoimmune Neurological Diseases: Insights from Preclinical StudiesDing Chen, Sandra Gallagher, Nancy L Monson, et al.
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Molecular Cancer Therapeutics|October 17, 2006
Induction of apoptosis by monastrol, an inhibitor of the mitotic kinesin Eg5, is independent of the spindle checkpointGregory M Chin, Ronald Herbst
Cancer Research|January 11, 2007
Potentiation of kinesin spindle protein inhibitor-induced cell death by modulation of mitochondrial and death receptor apoptotic pathwaysUlka Vijapurkar, Wei Wang, Ronald Herbst
The Journal of Biological Chemistry|September 18, 2002
The tyrosine phosphatase PRL-1 localizes to the endoplasmic reticulum and the mitotic spindle and is required for normal mitosisJing Wang, Celeste E Kirby, Ronald Herbst
International Journal of Rheumatic Diseases|October 23, 2012
Biomarkers for systemic lupus erythematosusRonald Herbst, Zheng Liu, Bahija Jallal, et al.
Cancer Metastasis Reviews|January 22, 2009
Kinesin motor proteins as targets for cancer therapyDennis Huszar, Maria-Elena Theoclitou, Jeffrey Skolnik, et al.
Arthritis Research & Therapy|April 10, 2013
B-cell targeted therapeutics in clinical developmentStephan Blüml, Kathleen McKeever, Rachel Ettinger, et al.
Molecular Immunology|June 9, 2014
Discerning the kinetics of autoimmune manifestations in a model of Sjögren's syndromeJodi L Karnell, Tamer I Mahmoud, Ronald Herbst, et al.
European Journal of Immunology|March 11, 2015
ICOS is required for the generation of both central and effector CD4(+) memory T-cell populations following acute bacterial infectionClare L Marriott, Gianluca Carlesso, Ronald Herbst, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2017
IL-22 Increases Permeability of Intestinal Epithelial Tight Junctions by Enhancing Claudin-2 ExpressionYaya Wang, John Brian Mumm, Ronald Herbst, et al.
Journal of Clinical Medicine|November 26, 2016
Inebilizumab, a B Cell-Depleting Anti-CD19 Antibody for the Treatment of Autoimmune Neurological Diseases: Insights from Preclinical StudiesDing Chen, Sandra Gallagher, Nancy L Monson, et al.
Pageof 8